Andrew Karlin, Managing Director at Edgemont Partners and Co-Head of the firm’s Global Pharmaceutical Services coverage, joined senior representatives from Martis Capital, Farragut Square, Health Catalyst Capital, and Volute Group in early November for Opus Connect’s NYC Healthcare Conference. He served as a panelist on the session titled “Investing in Pharmaceutical Services – Building Platforms,” which sparked an engaging discussion around innovation, scalability, and value creation in one of healthcare’s most dynamic segments. Panelists shared insights on where capital is flowing, how emerging technologies are transforming service models, and what it takes to build lasting platforms of scale in the space.